Direct oral anticoagulant use in patients with antiphospholipid syndrome and unprovoked venous thromboembolism: a single centre experience

被引：5
作者：
Doyle, Andrew J. [1 ]
Hunt, Beverley J. [1 ]
Danaee, Anicee [1 ]
Ling, Gavin [1 ]
Desborough, Michael J. [1 ,2 ]
Luo, Pulin [1 ]
Breen, Karen A. [1 ]
机构：
[1] St Thomas Hosp, Ctr Thrombosis & Haemostasis, London, England
[2] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 195卷 / 02期
关键词：
D O I：
10.1111/bjh.17634
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：276 / 278
页数：3
相关论文
共 11 条
  • [1] [Anonymous], 2019, DIR ACT OR ANT DOACS
  • [2] British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome (vol 157, pg 47, 2012)
    Arachchillage, Deepa R. J.
    Gomez, Keith
    Alikhan, Raza
    Anderson, Julia A. M.
    Lester, Will
    Laffan, Mike
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (02) : 212 - 215
  • [3] Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome
    Breen, Karen A.
    Seed, Paul
    Parmar, Kiran
    Moore, Gary W.
    Stuart-Smith, Sara E.
    Hunt, Beverley J.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) : 423 - 429
  • [4] Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
    Cohen, Hannah
    Hunt, Beverley J.
    Efthymiou, Maria
    Arachchillage, Deepa R. J.
    Mackie, Ian J.
    Clawson, Simon
    Sylvestre, Yvonne
    Machin, Samuel J.
    Bertolaccini, Maria L.
    Ruiz-Castellano, Maria
    Muirhead, Nicola
    Dore, Caroline J.
    Khamashta, Munther
    Isenberg, David A.
    [J]. Lancet Haematology, 2016, 3 (09): : E426 - E436
  • [5] Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis
    Elsebaie, Maha A. T.
    van Es, Nick
    Langston, Amelia
    Buller, Harry R.
    Gaddh, Manila
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (04) : 645 - 656
  • [6] International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    Miyakis, S
    Lockshin, MD
    Atsumi, T
    Branch, DW
    Brey, RL
    Cervera, R
    Derksen, RHWM
    De Groot, PG
    Koike, T
    Meroni, PL
    Reber, G
    Shoenfeld, Y
    Tincani, A
    Vlachoyiannopoulos, PG
    Krilis, SA
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) : 295 - 306
  • [7] Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial
    Ordi-Ros, Josep
    Saez-Comet, Luis
    Perez-Conesa, Mercedes
    Vidal, Xavier
    Riera-Mestre, Antoni
    Castro-Salomo, Antoni
    Cuquet-Pedragosa, Jordi
    Ortiz-Santamaria, Vera
    Mauri-Plana, Montserrat
    Sole, Cristina
    Cortes-Hernandez, Josefina
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 171 (10) : 685 - +
  • [8] Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
    Pengo, Vittorio
    Denas, Gentian
    Zoppellaro, Giacomo
    Jose, Seena Padayattil
    Hoxha, Ariela
    Ruffatti, Amelia
    Andreoli, Laura
    Tincani, Angela
    Cenci, Caterina
    Prisco, Domenico
    Fierro, Tiziana
    Gresele, Paolo
    Cafolla, Arturo
    De Micheli, Valeria
    Ghirarduzzi, Angelo
    Tosetto, Alberto
    Falanga, Anna
    Martinelli, Ida
    Testa, Sophie
    Barcellona, Doris
    Gerosa, Maria
    Banzato, Alessandra
    [J]. BLOOD, 2018, 132 (13) : 1365 - 1371
  • [9] Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism
    Savino, Sciascia
    Breen, Karen
    Hunt, Beverley J.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (04) : 476 - 477
  • [10] Immortal time bias in pharmacoepidemiology
    Suissa, Samy
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (04) : 492 - 499
12